Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations
暂无分享,去创建一个
Carlo Colosimo | Anette Schrag | Werner Poewe | Cristina Sampaio | Pablo Martínez-Martín | Olivier Rascol | Giovanni Fabbrini | W. Poewe | O. Rascol | G. Stebbins | C. Goetz | R. Hauser | P. Martínez-Martín | C. Sampaio | A. Schrag | M. Merello | C. Colosimo | G. Fabbrini | J. Miyasaki | Robert A Hauser | Marcelo Merello | Christopher G Goetz | Janis Miyasaki | Glenn T Stebbins
[1] G. Siegel,et al. Analysis of l-dopa induced dyskinesias in 51 patients with Parkinsonism , 1971, Journal of neurology, neurosurgery, and psychiatry.
[2] K. Dujardin,et al. Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.
[3] F. Walker. Intracerebral transplantation in movement disorders O. Lindvall, A. Björklund and H. Widner (eds.), Elsevier Science Publishers, Amsterdam, 360 pp., $184.50, ISBN 0-444-81364-0. , 1992, Journal of the Neurological Sciences.
[4] A J Lees,et al. Quantifying the impact of dyskinesias in PD , 2007, Neurology.
[5] C. Goetz,et al. Rating scales for dyskinesias in Parkinson's disease. , 1999, Movement disorders : official journal of the Movement Disorder Society.
[6] A. Lang,et al. Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment , 1994, Movement disorders : official journal of the Movement Disorder Society.
[7] D. Brooks,et al. Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.
[8] O. Rascol,et al. Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double‐blind placebo‐controlled trial , 2007, Movement disorders : official journal of the Movement Disorder Society.
[9] J. J. van Hilten,et al. Accelerometric assessment of levodopa‐induced dyskinesias in Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.
[10] A. Berardelli,et al. Onset and spread of dyskinesias and motor symptoms in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[11] K. Dujardin,et al. Anxiety rating scales in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.
[12] R. Sweet,et al. Reliability and applicability of movement disorder rating scales in the elderly. , 1993, The Journal of neuropsychiatry and clinical neurosciences.
[13] J. Jankovic,et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.
[14] Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease. , 2001, Archives of neurology.
[15] C. Goetz,et al. Levodopa‐induced dyskinesias , 2007, Movement disorders : official journal of the Movement Disorder Society.
[16] The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations , 2003, Movement disorders : official journal of the Movement Disorder Society.
[17] W. Poewe,et al. Scales to assess psychosis in Parkinson's disease: Critique and recommendations , 2008, Movement disorders : official journal of the Movement Disorder Society.
[18] F. Mastaglia,et al. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[19] Mones Rj,et al. Analysis of l-dopa induced dyskinesias in 51 patients with Parkinsonism , 1971 .
[20] William W. McDonald,et al. Depression rating scales in Parkinson's disease: Critique and recommendations , 2007, Movement disorders : official journal of the Movement Disorder Society.
[21] A. Berardelli,et al. Drug Insight: new drugs in development for Parkinson's disease , 2006, Nature Clinical Practice Neurology.
[22] H. Widner,et al. Clinical rating of dyskinesias in Parkinson's disease: Use and reliability of a new rating scale , 1999, Movement disorders : official journal of the Movement Disorder Society.
[23] J. Nutt,et al. The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile , 2008, Movement disorders : official journal of the Movement Disorder Society.
[24] J. Mcsherry. Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study , 2005, Neurology.
[25] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[26] R. Hauser,et al. Parkinson's disease home diary: Further validation and implications for clinical trials , 2004, Movement disorders : official journal of the Movement Disorder Society.
[27] J. D. Parkes,et al. Fluctuations of disability in Parkinson's disease – clinical aspects , 1981 .
[28] P. Martínez-Martín,et al. Scales to measure parkinsonism. , 2007, Handbook of clinical neurology.
[29] William J. Marks,et al. Deep Brain Stimulation Management: Abnormal Involuntary Movement Scale , 2010 .
[30] A. Whall,et al. Development of a Screening Program for Tardive Dyskinesia: Feasibility Issues , 1983, Nursing research.
[31] S Fahn,et al. Committee. Unified Parkinson’s Disease Rating Scale. , 2001 .
[32] R. Andreatini,et al. Reliability and clinical utility of a Portuguese version of the Abnormal Involuntary Movements Scale (AIMS) for tardive dyskinesia in Brazilian patients. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[33] P. Martínez-Martín,et al. Unified Parkinson's disease rating scale characteristics and structure , 1994, Movement disorders : official journal of the Movement Disorder Society.